Results 31 to 40 of about 7,488,458 (210)
Assessment of Disease Activity in Large-vessel Vasculitis
Objective. To arrive at consensus for candidate outcomes for disease activity assessment in large-vessel vasculitis (LVV) in clinical trials. Methods.
DİRESKENELİ, RAFİ HANER
core +1 more source
Evaluation and therapy in four patients with Takayasu′s arteritis
Takayasu′s arteritis (TA) is a large-vessel vasculitis primarily affecting the aorta and its branches. It ranks third among other types of childhood vasculitis, while it is the most common large vessel vasculitis observed in childhood.
S Conkar +4 more
doaj +1 more source
Lung Involvement in Pulmonary Vasculitis: A Radiological Review
Pulmonary vasculitis identifies a heterogeneous group of diseases characterized by inflammation, damage and necrosis of the wall of pulmonary vessels. The most common approach to classify vasculitis is according to etiology, therefore dividing them into ...
Luca Gozzi +11 more
doaj +1 more source
Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis. [PDF]
OBJECTIVE To evaluate contrast-enhanced magnetic resonance angiography (MRA) in diagnosis of inflammatory aortic involvement in patients with clinical suspicion of large-vessel vasculitis.
Wermelinger, Felix +17 more
core +2 more sources
Toward Reliable Uptake Metrics in Large Vessel Vasculitis Studies
The aim of this study is to investigate the influence of sex, age, fat mass, fasting blood glucose level (FBGL), and estimated glomerular filtration rate (eGFR) on blood pool activity in patients with large vessel vasculitis (LVV).
Gijs D. van Praagh +9 more
doaj +1 more source
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram +25 more
wiley +1 more source
A unique case of systemic lupus erythematosus with medium- and large-vessel vasculitis
Medium and large-vessel vasculitis in association with SLE is distinctly uncommon and is limited to occasional case reports only. We present a case of 40 year old female who presented with complaints of left sided pleuritic chest pain of 10 days duration.
Subbalaxmi V S. Malladi +4 more
doaj +1 more source
Virus and Autoimmunity: Can SARS-CoV-2 Trigger Large Vessel Vasculitis?
Introduction: Viral infections can induce autoimmune diseases in susceptible patients. SARS-CoV-2 has been associated with the development of rheumatic disease, especially small vessel vasculitis and arthritis. Typically, onset occurs days to weeks after
João Lázaro Mendes +4 more
doaj +1 more source
Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with inflammatory rheumatic disorders (IRDs). High‐resolution computed tomography (HRCT) is widely considered the gold standard for the noninvasive assessment of ILD; however, its interpretation is constrained by substantial interobserver variability and the ...
Alexander Pfeil +7 more
wiley +1 more source
Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio +28 more
wiley +1 more source

